Profil bibliographique

Amy A. Kirkwood

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

190Publications signalées

5337Citations signalées

4Affiliations récentes

Institutions déclarées

Cancer Research UK London Cancer CRUK Lung Cancer Centre of Excellence University College London

Domaines associés

Lymphoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia researchChronic Lymphocytic Leukemia ResearchCAR-T cell therapy researchLung Cancer Treatments and Mutations

Publications récentes

Accès ouvert 2025 articleOpenAlex

Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials

Amy A. Kirkwood, Sally F. Barrington, Heiko Schöder, Simonetta Viviani et autres

0 citationsCarolina Digital Repository (University of North Carolina at Chapel Hill)

Accès ouvert 2025 articleOpenAlex

New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System

Jahanzaib Khwaja, Amy A. Kirkwood, Paolo Milani, Binoy Yohannan et autres

10 citationsJournal of Clinical Oncology

2025 conference-abstractOpenAlex

A new validated staging system for AL amyloidosis with stage IIIc defining an ultra-poor prognostic in systemic AL amyloidosis in the modern treatment era

Jahanzaib Khwaja, Amy A. Kirkwood, Paolo Milani, Binoy Yohannan et autres

2 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Analysis of immune parameters and effect of immunoglobulin replacement therapy on infection, survival and non-relapse mortality following CD19 CAR T-cell therapy

Vaishali Dulobdas, Amy A. Kirkwood, Brijesh Gautama, Shenbagaram Kasivisvanathan et autres

1 citationBlood

2025 conference-abstractOpenAlex

PET-adaptive beacopp- versus ABVD-based therapies for advanced-stage (AS) classic Hodgkin lymphoma (cHL): Survival comparisons leveraging a multi-state model and analyzing the impact of a-hipi scores across the disease course

Cui Zhu, Angie Mae Rodday, Hocine Tighiouart, Nicholas Counsell et autres

1 citationBlood

Accès ouvert 2025 articleOpenAlex

Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials

Simonetta Viviani, Chiara Pavoni, Sally F. Barrington, Luca Guerra et autres

2 citationsBlood Cancer Journal

2025 letterOpenAlex

Reply to: “UKALL 2011: Flawed Noninferiority and Overlooked Interactions Undermine Conclusions” and “Understanding the Potential Importance of Pharmacokinetic Variability in the Setting of ALL”

Amy A. Kirkwood, Ajay Vora

0 citationsJournal of Clinical Oncology

Accès ouvert 2025 articleOpenAlex

CD19 chimeric antigen receptor T‐cell efficacy and toxicity in adults with Richter's transformation and response to bridging therapy

Angela Hwang, Amy A. Kirkwood, Maeve O’Reilly, Lorna Neill et autres

0 citationsBritish Journal of Haematology

Accès ouvert 2025 articleOpenAlex

782 | GAME SET AND MATCH FOR CAR‐T IN DLBCL? WHY TREATMENT BIAS AGAINST BISPECIFIC ANTIBODIES MAY MAKE MATCHED REAL‐WORLD COMPARISONS UNINTERPRETABLE

Amy A. Kirkwood, Claire Roddie, Tobias Menne, Michael Northend et autres

0 citationsHematological Oncology

Accès ouvert 2025 articleOpenAlex

662 | OUTCOMES WITH CAR‐T AND SUBSEQUENT THERAPIES IN PATIENTS WITH T CELL HISTIOCYTE‐RICH LARGE B‐CELL LYMPHOMA, UK EXPERIENCE

Dima El Sharkawi, Amy A. Kirkwood, A. Abdulgawad, David Irvine et autres

0 citationsHematological Oncology

Accès ouvert 2025 articleOpenAlex

459 | OUTCOMES OF SECOND‐LINE AXICABTAGENE CILOLEUCEL FOR LARGE B‐CELL LYMPHOMA IN THE UK

Andrea Kühnl, Amy A. Kirkwood, Michael Northend, Caroline Besley et autres

0 citationsHematological Oncology

Accès ouvert 2025 articleOpenAlex

15 | EARLY PET RESPONSE PREDICTS RISK OF RELAPSE AFTER 2L AXI‐CEL IN LARGE B‐CELL LYMPHOMA

Andrea Kühnl, Amy A. Kirkwood, Michael Northend, Caroline Besley et autres

0 citationsHematological Oncology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.